Menu
GeneBe

LDLRAD4

low density lipoprotein receptor class A domain containing 4, the group of MicroRNA protein coding host genes

Basic information

Region (hg38): 18:13217497-13652755

Previous symbols: [ "C18orf1" ]

Links

ENSG00000168675NCBI:753OMIM:606571HGNC:1224Uniprot:O15165AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LDLRAD4 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LDLRAD4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
12
clinvar
1
clinvar
13
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 1 0

Variants in LDLRAD4

This is a list of pathogenic ClinVar variants found in the LDLRAD4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-13438289-C-T not specified Uncertain significance (Dec 17, 2023)3118291
18-13621128-T-C not specified Uncertain significance (Jul 11, 2023)2603046
18-13621231-G-A Likely benign (Jan 01, 2023)2648606
18-13621234-C-T not specified Uncertain significance (Sep 23, 2023)3118288
18-13621246-G-A not specified Uncertain significance (Jan 09, 2024)3118289
18-13621267-C-T not specified Uncertain significance (May 10, 2022)2288317
18-13643386-G-A not specified Uncertain significance (May 31, 2024)3290412
18-13643402-G-A not specified Uncertain significance (Jul 25, 2023)2613695
18-13643408-C-T not specified Uncertain significance (Dec 16, 2022)2412049
18-13645143-G-A not specified Uncertain significance (Jul 20, 2021)2301656
18-13645187-C-T not specified Uncertain significance (May 24, 2023)2568302
18-13645227-A-G not specified Uncertain significance (Oct 26, 2022)2320536
18-13645436-A-T not specified Uncertain significance (Apr 05, 2023)2533375
18-13645473-G-A not specified Uncertain significance (Jun 10, 2024)3290413
18-13645503-G-T not specified Uncertain significance (Dec 16, 2023)3118290

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LDLRAD4protein_codingprotein_codingENST00000361205 5435258
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6200.378125743041257470.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.571372000.6860.00001282019
Missense in Polyphen4483.3690.52778846
Synonymous-0.1898885.81.030.00000631603
Loss of Function2.63211.70.1716.71e-7120

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00002640.0000264
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functions as a negative regulator of TGF-beta signaling and thereby probably plays a role in cell proliferation, differentiation, apoptosis, motility, extracellular matrix production and immunosuppression. In the canonical TGF-beta pathway, ZFYVE9/SARA recruits the intracellular signal transducer and transcriptional modulators SMAD2 and SMAD3 to the TGF-beta receptor. Phosphorylated by the receptor, SMAD2 and SMAD3 then form a heteromeric complex with SMAD4 that translocates to the nucleus to regulate transcription. Through interaction with SMAD2 and SMAD3, LDLRAD4 may compete with ZFYVE9 and SMAD4 and prevent propagation of the intracellular signal. {ECO:0000269|PubMed:24627487}.;

Recessive Scores

pRec
0.0990

Intolerance Scores

loftool
rvis_EVS
-0.12
rvis_percentile_EVS
45.13

Haploinsufficiency Scores

pHI
0.539
hipred
Y
hipred_score
0.692
ghis
0.504

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ldlrad4
Phenotype
immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
negative regulation of epithelial to mesenchymal transition;negative regulation of SMAD protein complex assembly;negative regulation of cell migration;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of pathway-restricted SMAD protein phosphorylation
Cellular component
nucleoplasm;integral component of membrane;early endosome membrane;intracellular membrane-bounded organelle
Molecular function
R-SMAD binding